| Financial Year |
March 31 2023 |
| Monetary Funds |
576,807,610.03 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
825,349,112.25 |
| Advances to Suppliers |
392,634,006.39 |
| Other Receivables |
387,907,609.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
12,964,624.01 |
| Inventories |
3,785,913,739.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
179,008,413.94 |
| Total Current Assets |
6,236,056,422.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
149,585,623.53 |
| Long-term Equity Investment |
1,349,885,906.47 |
| Investment Properties |
769,993,573.60 |
| Fixed Assetes |
2,412,936,136.83 |
| Under-construction Projects |
849,939,091.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,504,517,131.39 |
| R&D expenses |
-- |
| Goodwill |
432,760,628.22 |
| Long-Term Deferred and Prepaid Expenses |
24,235,416.10 |
| Deferred Income Tax Assets |
807,084,486.47 |
| Other Non-Current Assets |
618,448,500.03 |
| Sub-Total of Non-Current Assets |
11,462,434,363.88 |
| Total Assets |
17,698,490,785.98 |
| Short-Term Loans |
1,112,561,532.34 |
| Trading Financial liabilities |
417,489,358.05 |
| Notes Payable |
29,247,044.02 |
| Accounts Payable |
1,352,404,291.65 |
| Accounts Received In Advance |
26,069,496.99 |
| Employee Compensation Payable |
222,615,723.20 |
| Taxes Payable |
180,082,756.87 |
| Interest Payable |
164,907,106.00 |
| Dividend Payable |
1,890,000.00 |
| Other payables |
1,752,415,450.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,403,926,679.05 |
| Other Current Liabilities |
446,327,014.42 |
| Sub-Total of Current Liabilities |
9,663,400,323.54 |
| Long-term Loans |
1,273,744,883.63 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
12,662,167.10 |
| Special Payable |
-- |
| Estimatied Liabilities |
783,587,459.70 |
| Deferred Income Tax Liabilities |
147,325,975.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,727,547,775.60 |
| Total Liabilities |
12,390,948,099.14 |
| Paid-In Capital(Or Share Stock) |
7,894,663,678.00 |
| Capital Surplus |
7,802,528,302.87 |
| Surplus Reserve |
196,165,027.15 |
| LESS:Treasury Stock |
1,678,254,971.40 |
| Undistributed Profits |
-9,812,912,473.41 |
| Minority Stockholder's Interest |
903,520,418.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,404,022,267.96 |
| Owner's Equity（Stockholder's Equity） |
5,307,542,686.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,698,490,785.98 |
